#United States #New York #healthcare #Market Trends #Quest Diagnostics

Quest Diagnostics at the Baird 2025 Global Healthcare Conference

Quest Diagnostics Incorporated (NYSE: DGX), a frontrunner in diagnostic information services, has announced that its Chairman, CEO, and President, Jim Davis, will be delivering a speech at the highly anticipated Baird 2025 Global Healthcare Conference. The event will take place on September 10, 2025, at 10:50 a.m. Eastern Time, in the bustling heart of New York City.

During this key session, Davis will delve into the company's strategic direction, explore its performance metrics, and highlight the latest market developments and trends. This comes as Quest Diagnostics continues to play a pivotal role in the healthcare landscape, offering valuable insights derived from an extensive database of clinical lab results.

The discussion will not only showcase Quest’s commitment to harnessing diagnostic insights but also how these results empower individuals, healthcare providers, and organizations to make informed decisions that improve health outcomes. Following the talk, there will be a fireside chat and an interactive Q&A session, inviting participants to engage and gain deeper understanding of the company’s initiatives.

For those unable to attend in person, the conference will be webcast live, accessible via the investor relations page of Quest Diagnostics. This webcast will also be archived and available for viewing for 24 hours post-event, allowing a broader audience to absorb the insights shared during the discussion.

About Quest Diagnostics

Quest Diagnostics is committed to enhancing the health of individuals through the power of diagnostic information. The company's innovative testing services cater to diverse healthcare needs, offering solutions that resonate across the healthcare ecosystem. With over 55,000 employees, Quest Diagnostics serves one-third of adult Americans and collaborates with half of the physicians and hospitals in the United States.

Leveraging one of the largest databases of de-identified clinical lab results globally, Quest is at the forefront of discovering new methods for identifying and treating diseases. It aims to inspire positive health behaviors and improve overall healthcare management, as indicated by its mission: "to create a healthier world, one life at a time."

Conclusion

The Baird 2025 Global Healthcare Conference is set to be a defining moment as Quest Diagnostics reveals its strategic vision and insights. This event promises valuable discussions pertinent to future healthcare trends, and the participation of key industry leaders like Jim Davis assures a wealth of knowledge for attendees. Keep an eye out for the live stream that promises to keep you informed on all things Quest and their ongoing efforts in the healthcare sector.

To learn more about Quest Diagnostics and its wide array of services, visit www.QuestDiagnostics.com.